125 related articles for article (PubMed ID: 31478152)
21. Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model.
Ohnishi H; Kawasaki T; Deguchi T; Yuba S
Cell Reprogram; 2015 Aug; 17(4):268-74. PubMed ID: 26090552
[TBL] [Abstract][Full Text] [Related]
22. Truncated XPA protein detected in atypical group A xeroderma pigmentosum.
Mimaki T; Nitta M; Saijo M; Tachi N; Minami R; Tanaka K
Acta Paediatr; 1996 Apr; 85(4):511-3. PubMed ID: 8740317
[TBL] [Abstract][Full Text] [Related]
23. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
24. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein.
States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE
Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271
[TBL] [Abstract][Full Text] [Related]
25. Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.
Christen-Zaech S; Imoto K; Khan SG; Oh KS; Tamura D; Digiovanna JJ; Boyle J; Patronas NJ; Schiffmann R; Kraemer KH; Paller AS
Arch Dermatol; 2009 Nov; 145(11):1285-91. PubMed ID: 19917958
[TBL] [Abstract][Full Text] [Related]
26. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M; Ueda M; Ichihashi M
Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
[TBL] [Abstract][Full Text] [Related]
27. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation.
Musich PR; Li Z; Zou Y
Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689
[TBL] [Abstract][Full Text] [Related]
28. High levels of oxidatively generated DNA damage 8,5'-cyclo-2'-deoxyadenosine accumulate in the brain tissues of xeroderma pigmentosum group A gene-knockout mice.
Mori T; Nakane H; Iwamoto T; Krokidis MG; Chatgilialoglu C; Tanaka K; Kaidoh T; Hasegawa M; Sugiura S
DNA Repair (Amst); 2019 Aug; 80():52-58. PubMed ID: 31279170
[TBL] [Abstract][Full Text] [Related]
29. Compound heterozygous group A xeroderma pigmentosum patient with a novel mutation and an inherited reciprocal translocation.
Maeda T; Sato K; Tanaka T; Minami H; Taguchi H; Mimaki T; Yoshikawa K
Br J Dermatol; 2000 Jul; 143(1):174-9. PubMed ID: 10886156
[TBL] [Abstract][Full Text] [Related]
30. A novel XPA splice-site mutation identified in a 4-year-old Filipino girl with xeroderma pigmentosum.
Reyes HH; Lin YC; Hsu CK; Guevara BEK
Australas J Dermatol; 2023 May; 64(2):e165-e167. PubMed ID: 36866916
[TBL] [Abstract][Full Text] [Related]
31. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.
Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T
Mutat Res; 2001 Jun; 477(1-2):31-40. PubMed ID: 11376684
[TBL] [Abstract][Full Text] [Related]
32. [Neurological manifestations of xeroderma pigmentosum].
Boutaleb N; Ouhabi H; Bourazza A; Mosseddaq R
Rev Neurol (Paris); 2000 Sep; 156(8-9):790-3. PubMed ID: 10992126
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiology.
Ortega-Recalde O; Vergara JI; Fonseca DJ; Ríos X; Mosquera H; Bermúdez OM; Medina CL; Vargas CI; Pallares AE; Restrepo CM; Laissue P
PLoS One; 2014; 8(6):e64692. PubMed ID: 23755135
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
[TBL] [Abstract][Full Text] [Related]
36. Xeroderma pigmentosum complementation group F: A rare cause of cerebellar ataxia with chorea.
Carré G; Marelli C; Anheim M; Geny C; Renaud M; Rezvani HR; Koenig M; Guissart C; Tranchant C
J Neurol Sci; 2017 May; 376():198-201. PubMed ID: 28431612
[TBL] [Abstract][Full Text] [Related]
37. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.
Hirai Y; Kodama Y; Moriwaki S; Noda A; Cullings HM; Macphee DG; Kodama K; Mabuchi K; Kraemer KH; Land CE; Nakamura N
Mutat Res; 2006 Oct; 601(1-2):171-8. PubMed ID: 16905156
[TBL] [Abstract][Full Text] [Related]
38. Mutation and expression of the XPA gene in revertants and hybrids of a xeroderma pigmentosum cell line.
Cleaver JE; McDowell M; Jones C; Wood R; Karentz D
Somat Cell Mol Genet; 1994 Jul; 20(4):327-37. PubMed ID: 7974007
[TBL] [Abstract][Full Text] [Related]
39. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
40. Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders.
Okamura K; Sakaguchi H; Sakamoto-Abutani R; Nakanishi M; Nishimura K; Yamazaki-Inoue M; Ohtaka M; Periasamy VS; Alshatwi AA; Higuchi A; Hanaoka K; Nakabayashi K; Takada S; Hata K; Toyoda M; Umezawa A
Sci Rep; 2016 May; 6():26342. PubMed ID: 27197874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
